Felvizumab
Alternative Names: HuRSV19VHFNS/VK; RSHZ19; RSV monoclonal antibody; SB 209763Latest Information Update: 28 Mar 2001
At a glance
- Originator Scotgen [CEASED]
- Class Antivirals; Monoclonal antibodies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Respiratory syncytial virus infections
Most Recent Events
- 28 Mar 2001 Discontinued-II for Respiratory syncytial virus infections in United Kingdom (Unknown route)
- 28 Mar 2001 Discontinued-III for Respiratory syncytial virus infections in USA (Unknown route)
- 23 Jan 2001 SmithKline Beecham has merged with Glaxo Wellcome to form GlaxoSmithKline